Semaglutide affects both the brain and the digestive system to help regulate appetite and eating patterns. It is a GLP-1 receptor agonist, meaning it mimics a natural hormone that signals fullness and reduces hunger.
What is Semaglutide?
Semaglutide is a treatment medicine used to treat type 2 diabetes and support chronic weight management. It goes to a class of drugs called GLP-1 receptor agonists, which mimic a natural hormone that helps control blood sugar and appetite.
Semaglutide works by stimulating insulin secretion, reducing excess glucose production, slowing stomach emptying, and decreasing hunger, which can lead to weight loss. It is obtainable under brand names such as Ozempic, Wegovy, and Rybelsus, and is taken either as a weekly injection or a daily oral tablet, depending on the brand.
How Does Semaglutide Affect Appetite and Eating Behaviour?
| Effect Area | How Semaglutide Works | Impact on Appetite & Eating Behaviour |
| Hunger Signals | Mimics GLP-1 hormone and acts on appetite centers in the brain (hypothalamus) | Reduces overall hunger levels |
| Feeling of Fullness | Slows gastric emptying (food stays longer in the stomach) | You feel full faster and for longer periods |
| Cravings | Influences brain reward pathways linked to food | Reduces cravings, especially for high-calorie foods |
| Portion Size | Enhances satiety signals during meals | Naturally leads to smaller portion sizes |
| Snacking Frequency | Decreases desire to eat between meals | Fewer impulsive or emotional eating episodes |
| Blood Sugar Stability | Improves insulin release and reduces glucose spikes | Helps prevent hunger caused by rapid blood sugar drops |
| Emotional Eating | May reduce food-reward response | Less stress-related or boredom eating |
| Food Preferences | Some users report reduced desire for fatty or sugary foods | Healthier food choices over time |
| Eating Speed | Increased satiety awareness | Encourages slower, more mindful eating |
| Long-Term Weight Control | Sustained appetite suppression | Supports gradual, sustainable weight loss |
How Must Semaglutide Be Used?
Semaglutide must always be used under medical supervision, as dosage and suitability depend on your health condition (type 2 diabetes or weight management).
1. Forms of Semaglutide
Semaglutide is available as:
- Weekly injection (under the skin)
- Daily oral tablet (for diabetes only)
The injection is commonly prescribed for weight management and diabetes, while the tablet is mainly for type 2 diabetes.
2. Dosage Schedule (Typical for Injection)
Semaglutide is started at a low dose to reduce side effects and gradually increased.
Example dose escalation (may vary by prescription):
- Low starting dose for 4 weeks
- Increased gradually every 4 weeks
- Target maintenance dose after several months
Your doctor adjusts this based on tolerance and response.
3. How to Take the Injection
- Inject once weekly, same day each week
- Inject under the skin (abdomen, thigh, or upper arm)
- Can be taken with or without food
- Rotate injection sites weekly
If you miss a dose:
- Take it within 5 days if possible
- If more than 5 days, skip and continue next scheduled dose
4. How to Take the Oral Tablet (if prescribed)
- Take once daily
- On an empty stomach
- With a small amount of water
- Wait at least 30 minutes before eating or drinking anything else
5. Lifestyle Support
Semaglutide works best when combined with:
- Balanced, calorie-controlled diet
- Regular physical activity
- Good hydration
- Avoiding overeating (especially during nausea phase)
Tablets and Injection of Semaglutide
| Country | Form | Brand/Type | Typical Dose | Approx. Monthly Price (Self-Pay) |
| India | Tablet | Rybelsus (for diabetes) | 3 mg / 7 mg / 14 mg | ~₹3,149 – ₹3,520 per 10-tablet pack (≈ ₹9,000+ per month if taken daily) |
| India | Injection | Ozempic (for diabetes) | 0.25 mg | ~₹8,800 / month |
| 0.5 mg | ~₹10,170 / month | |||
| 1 mg | ~₹11,175 / month | |||
| India | Injection | Wegovy (for weight loss) | 0.25 mg | ~₹10,850 / month |
| 0.5 mg & 1 mg | ~₹13,850 / month | |||
| 1.75 mg | ~₹16,400 / month | |||
| 2.4 mg (max) | ~₹16,400 / month | |||
| United Kingdom | Tablet | Oral semaglutide (private) | various | ~£100 – £200+ per month (private) |
| United Kingdom | Injection | Wegovy (semaglutide) | 1 pen (4 doses) | ~£99 per 4-week supply (private) |
| United States | Tablet | Wegovy (oral GLP-1) | starting dose | ~$149 / month (lower doses, self-pay) and ~$349+ / month for higher doses |
| United States | Injection | Wegovy (semaglutide) | typical weight-loss dosing | ~$1,349 / month (list price; can be lower with discounts/insurance) |
| United States | Injection | Ozempic (semaglutide) | typical dosing | ~$950 – $1,372 / month (list; varies by dose and pharmacy) |
Mechanism of Action – Semaglutide
Semaglutide works by mimicking a natural hormone in the body called GLP-1 (glucagon-like peptide-1). This hormone is released from the gut after eating and helps regulate blood sugar, digestion, and appetite.
Step-by-Step Mechanism
1️. Binds to GLP-1 Receptors
Semaglutide attaches to GLP-1 receptors located in:
- Pancreas
- Brain
- Stomach
- Liver
This activates the same pathways as the natural GLP-1 hormone — but for a longer duration.
2️. Increases Insulin Release (Glucose-Dependent)
When blood sugar levels are high:
- It stimulates the pancreas to release insulin
- Insulin helps move glucose from the bloodstream into cells
Important: It works mainly when glucose is elevated, reducing risk of low blood sugar (hypoglycemia).
3️. Reduces Glucagon Secretion
Glucagon is a hormone that raises blood sugar.
Semaglutide:
- Decreases glucagon release
- Reduces glucose production by the liver
This helps lower overall blood sugar levels.
4️. Slows Gastric Emptying
It delays how quickly food leaves the stomach.
Result:
- Food stays longer in the stomach
- Slower absorption of glucose
- Prolonged feeling of fullness
5️. Acts on the Brain (Appetite Control)
Semaglutide affects appetite-regulating centers in the hypothalamus.
This leads to:
- Reduced hunger
- Increased satiety
- Lower calorie intake
- Decreased cravings
Overall Effects
- Improves blood glucose control
- Supports weight loss
- Reduces appetite
- May lower cardiovascular risk in certain patients
Benefits of Semaglutide
| Benefit | How It Helps | Long-Term Impact |
| Appetite Reduction | Lowers hunger signals in the brain | Helps control calorie intake |
| Weight Loss Support | Increases fullness and reduces cravings | Sustainable weight reduction when combined with lifestyle changes |
| Improved Blood Sugar Control | Stimulates insulin and lowers glucose production | Better diabetes management |
| Reduced Cravings | Decreases desire for sugary and high-fat foods | Healthier eating habits |
| Portion Control | Makes you feel full faster | Naturally smaller meal sizes |
| Cardiovascular Benefits | May reduce risk of heart-related events in high-risk patients | Improved heart health outcomes |
| Slower Digestion | Keeps food in the stomach longer | Prolonged satiety and fewer snacks |
| Once-Weekly Dosing (Injection) | Convenient administration schedule | Better treatment adherence |
| Reduced “Food Noise” | Decreases constant thoughts about eating | Improved mental focus and eating control |
| Supports Metabolic Health | Helps regulate insulin and blood sugar levels | Lower risk of metabolic complications |
What are the Negative Side Effects of Semaglutide?
The negative side of semaglutide comprises several side effects and possible risks. Common side effects are nausea, vomiting, diarrhea, constipation, stomach pain, and loss of appetite, particularly when taking the medicine for the first time.
Some people may experience exhaustion, dizziness, or dyspepsia. More thoughtful but rare risks include pancreatitis (inflammation of the pancreas), gallbladder problems, kidney issues due to thirst, and low blood sugar when combined with insulin or extra diabetes tablets.
In animal studies, semaglutide has been related to thyroid tumors, so it is not recommended for people with a personal or family history of medullary thyroid cancer. Medications like Ozempic and Wegovy must be used only under medical supervision.
Is Semaglutide Available in India?
| Form of Semaglutide | Brand / Description | Available in India? | Notes |
| Semaglutide | Rybelsus | Yes | Putative and sold for type 2 diabetes. |
| Injectable semaglutide for diabetes | Ozempic | Yes | It was recently accepted and approved in India for the treatment of type 2 diabetes. |
| Injectable semaglutide for weight loss | Wegovy | Limited / Select | Known and hurled, but obtainability can vary by drugstore. |
| New generic injectable semaglutide | Obeda, Semaglyn, Mashema, Altreme, Sematrinity | Soon / Continuing approvals | Generic wine by Indian builders expected after obvious finish (2026). |
Treatment Of Semaglutide
Semaglutide is used as a medical treatment for type 2 diabetes and chronic weight management. It works by imitating the GLP-1 hormone, which helps control blood sugar levels, decrease appetite, and promote a feeling of fullness.
When set for diabetes, it restores insulin release and lowers excess glucose production. For weight management, it helps reduce calorie intake and supports steady, sustained weight loss.
Semaglutide is available as a once-weekly injection, such as Ozempic (for diabetes) and Wegovy (for overweight), as well as an everyday oral tablet called Rybelsus. It is most effective when combined with a healthy diet, regular exercise, and ongoing medical management.
Key Points
Agreed for type 2 diabetes and obesity/overweight
Occupied as a once-weekly injection or a daily oral tablet
Starts at a low dose and slowly increases
Helps control blood sugar levels
Reduces hunger and supports weight loss
May lower circulatory risk in some affected roles
Must be used along with diet and exercise
Necessitates even medical monitoring.
Best Hospital of Semaglutide
India
| Hospital / Centre | City | Relevant Specialty | Typical Consult Fee (Approx.) |
| EQUA – Center of Excellence for Obesity Care | Bengaluru | Obesity, Metabolic Medicine, GLP-1 therapy | ₹1,000 – ₹2,500 per visit* |
| Fortis Healthcare (Diabetes & Obesity Clinics) | Delhi, Gurgaon, Mumbai, Bengaluru, etc. | Endocrinology, Diabetes & Weight Management | ₹1,500 – ₹3,000* |
| Asian Diabetes & Thyroid Hormone Super Speciality Centre | Delhi | Diabetes, Metabolic Disorders | ₹1,000 – ₹2,500* |
| Max Super Speciality Hospital (Endocrinology) | New Delhi | Diabetes & Endocrinology | ₹1,500 – ₹3,000* |
| Dr. Mohan’s Diabetes Specialities Centre | Chennai & Other Cities | Diabetes & Metabolic Care | ₹1,000 – ₹2,500* |
| Lilavati Hospital – Diabetes & Endocrinology | Mumbai | Endocrinology & Diabetes | ₹1,500 – ₹3,000* |
| All India Institute of Medical Sciences (AIIMS) | New Delhi | Endocrinology & Metabolic Disorders | ₹300 – ₹900* |
| Private Endocrinology Specialists (Selected Clinics) | Major Cities | Personalized diabetes/metabolic care | ₹800 – ₹2,000* |
China
| Hospital / Clinic | City/Province | Focus / Specialty | Typical Consult / Service Fee (Approx.) |
| Ruijin Hospital, Shanghai Jiao Tong Univ. | Shanghai | Top endocrinology & metabolic care | Public consult ~¥100–¥300¹ + advanced assessment costs*(MedTourChina) |
| Peking Union Medical College Hospital | Beijing | Endocrinology, diabetes & metabolic disorders | Public consult ~¥100–¥300* |
| West China Hospital (Dept. Endocrinology) | Chengdu | Diabetes, metabolic diseases & obesity care | Public consult ~¥100–¥300* |
| Shanghai Sixth People’s Hospital – Weight Management / Endocrine | Shanghai | Multidisciplinary weight & metabolic clinic | Public outpatient ~¥100–¥300 + tests* |
| Beijing Ruijing Diabetes Hospital | Beijing / Harbin / Chengdu | Diabetes specialty care & metabolic assessment | Consult varies by clinic (private/dedicated diabetes) |
| Jiahui International Hospital (Bariatric Clinic) | Shanghai & multiple cities | Private metabolic and bariatric care | Private consult ~¥500–¥1,500+* |
| Qingdao Municipal Hospital – Weight Management Center | Qingdao | Multidisciplinary weight & metabolic services | Public consult ~¥100–¥300 + package programs* |
| Multidisciplinary Weight Management Clinics (various public hospitals) | Nationwide | Integrated metabolic/endocrine/nutrition care | Public consult ~¥100–¥300* |
Risks of Unapproved Versions of Semaglutide
| Type of Version | What It Is | Approved by Regulator? | Main Risks | Important Notes |
| Combined Semaglutide | Custom-made version prepared by a combination pharmacy | Not FDA/CDSCO-approved as a branded product | Incorrect dosing, contamination, and safety not fully tested | Sometimes promoted during shortages of Ozempic or Wegovy |
| Research-grade / “For laboratory use only.” | Sold online, labeled for research purposes | No medical approval | Nameless purity, unsafe for human use | Not legally accepted for treatment |
| Forged Products | Fake types are sold illegally | Illegal & unregulated | Wrong ingredients, no active drug, or damaging substances | Often sold online or through illegal sellers |
| Semaglutide Salts (e.g., sodium/acetate rayon forms) | Chemical differences not used in approved drugs | Not approved for treatment | Safety and efficiency not established | Accepted brands use the semaglutide base form |
| Introduced without authorization | Crops brought from other countries without controlling clearance | Not locally approved | Storing issues, authenticity anxieties | May disrupt local drug laws |
Signs and Symptoms of Overdose – Semaglutide
An overdose of semaglutide (such as Ozempic or Wegovy) can lead to deepened side effects, mainly affecting the digestive system and blood sugar levels.
Since semaglutide works by decelerating digestion and increasing insulin release, taking too much may result in plain nausea, recurring vomiting, dehydration, and low blood sugar (particularly in people who also use insulin or other diabetes medicines).
Indications can last for numerous days due to the long-acting countryside of the drug. Instant medical care is important if a thoughtful overdose is suspected.
Key Points (Symptoms of Overdose) are:
Severe or tenacious nausea
Repeated sickness
Severe diarrhea
Stomach pain
Dryness (dry mouth, dizziness, reduced urination)
Low blood sugar (trembling, sweating, confusion, weakness)
Collapsing or extreme exhaustion.
Illegally Marketed Versions of Semaglutide
| Type of Illegal Version | How It Is Marketed | Legal Status | Main Risks | Warning Signs |
| Counterfeit branded pens | Sold as fake Ozempic or Wegovy online | Illegal | Wrong ingredients, no active drug, contamination | Very low price, spelling errors, no prescription required |
| Black-market imports | Smuggled from other countries without approval | Illegal in many regions | Improper storage, expired stock, and authenticity issues | No verified drugstore, no batch tracking |
| “Research use only” semaglutide | Labeled for lab use but vended for weight loss | Not accepted for human use | Unidentified purity, unsafe for injection | Sold on chemical supply websites |
| Social media weight-loss challenges | Marketed via influencers or private vendors | Often free | Improper dosing, fake or weak drug | No approved pharmacy is involved |
| Semaglutide salts (sodium/acetate rayon) are sold as alternatives | Indorsed as a cheaper alternative | Not an approved drug form | Safety and efficiency are not recognized | No official drug labeling |
Conclusion
Once-weekly semaglutide has developed into an important treatment choice for adults with overweight or obesity. Reducing appetite, improving roundedness, and refining blood sugar control can lead to important and sustained weight loss when combined with healthy lifestyle habits. The medication, typically set as Wegovy, has exposed robust clinical penalties. Still, it must be used below medical supervision due to likely side effects such as nausea, peptic issues, and rare but serious risks.